Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin in Metastatic Pancreatic Adenocarcinoma
NCT01339754Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2011
- Primary completion
- Dec 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in pancreatic adenocarcinoma (PDAC), sponsored by IRCCS Ospedale San Raffaele. Started Feb 2011; status: completed.
02
Drugs
trabectedin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01339754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339754.